Built for the new generation of airline and travel retail, OSO turns payments into a commercial advantage DALLAS, Sept. 22,…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
Jakarta, 17 September 2025. During today’s press conference, Messe Frankfurt announced the expansion of the Automechanika trade fair brand in…
Bidirectional charging has been possible on a technical level for a long time. So what is holding back the potential…
Citadel, BlackRock, Vanguard, Jane Street, Northern Trust, Man Group, and State Street amongst others take positions as institutional ownership surpasses…
Study of 300+ executives identifies misalignment between marketing and IT as key barrier to AI transformation CHICAGO, Sept. 10, 2025…
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi companyKER-0193, a novel, orally bioavailable…
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing…
- MLK listed on Binance Alpha on August 16, highlighting service reliability and growth potential - MiL.k aims to become…